M 475
Pill imprint M 475 has been identified as Nifedipine ER 30 mg.
Nifedipine is used in the treatment of high blood pressure; raynaud's syndrome; angina pectoris prophylaxis; migraine prevention; hypertrophic cardiomyopathy (and more), and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy.
Nifedipine 30 mg is not subject to the Controlled Substances Act.
See also related documents.
Nifedipine ER Images
- Imprint:
-
M 475
- Strength:
- 30 mg
- Color:
- Pink
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- cellulose acetate
hydroxypropyl cellulose
hypromellose
magnesium stearate
polyethylene glycol
ferric oxide red
sodium chloride
titanium dioxide
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-3475
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0940 | UDL Laboratories Inc |
| 54569-5155 | A S Medication Solutions LLC (repackager) |
| 49999-0357 | Lake Erie Medical and Surgical Supply (repackager) |
| 66336-0683 | Dispensing Solutions Inc. (repackager) |
| 68258-1019 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Nifedipine ER resources
- Nifedipine
- Nifedipine (Wolters Kluwer)
- Nifedipine Sustained-Release Tablets (Wolters Kluwer)
- nifedipine (Cerner Multum)
- nifedipine (Micromedex) - Includes Dosage Information
- Nifedipine (AHFS DI)
- Nifedipine Capsules (FDA)
- Nifedipine Extended-Release Tablets (FDA)
- Nifedipine (Wolters Kluwer)
Search Again
